Horizon’s research was cited in a recent Wall Street Journal article about the Inflation Reduction Act’s drug pricing negotiations.
CBO predicted only a dozen drugs would be lost by 2039, but four months into the Inflation Reduction Act the consulting firm Horizon Government Affairs found that at least 24 companies had announced that they’re curtailing drug development owing to the bill.